Tag: Cardiolipin

Did you know that the synthetic peptide SS-31, also known as elamipretide, can accumulate within the mitochondria of cells at concentrations up to 5,000 times higher than in other cellular areas? This remarkable selectivity is key to understanding precisely what does SS 31 do, focusing its therapeutic effects on the cell's energy-producing powerhouse.

Mitochondrial dysfunction is a central factor in many age-related diseases and overall decline, leading to reduced energy and increased cellular damage. SS-31 peptide, also known as Elamipretide, is a groundbreaking, mitochondria-targeting compound designed to specifically address this root cause by stabilizing and optimizing mitochondrial function.

Following the accelerated FDA approval of elamipretide (SS-31) for Barth syndrome in September 2025, this novel mitochondria-targeted peptide has garnered significant attention for its role in cellular bioenergetics. SS-31's primary function is to protect and restore the function of damaged mitochondria, which are the cellular powerhouses responsible for energy production.